NVS vs TMO

Novartis AG against Thermo Fisher Scientific — live side-by-side technical comparison.

Prices as of 2026-11-10T21:00:02+00:00 UTC · updates daily

Who leads right now

Neither name has a clear edge: they split the windows 3–3 — over 1 month NVS is +13.6% and TMO +9.2%; over year to date NVS is +18.4% and TMO +23.9%. The NVS/TMO price ratio stands at 0.2273, above its 50-day average of 0.2247, and below the 200-day average of 0.2806. A ratio above its own average means NVS is gaining on TMO; on this reading the recent edge belongs to NVS.

NVS/TMO over the last year

NVS/TMO price ratio · dashed: its 50- and 200-day lines · ratio above its 50-day line = NVS gaining on TMO
0.2030.25010.29720.3443
Both rebased to 100 on 2025-11-10
94.14100114.5132.4NVSTMO
Ask
Compare NVS and TMO: which has been stronger over the last year, and where does each stand against its 200-day average? Ask the analyst about this pair →

Performance side by side

NVSTMO
Price$163.26 $718.20
1 day -0.3%lead -0.5%
5 days +2.5% +2.8%lead
1 month +13.6%lead +9.2%
6 months +11.8% +54.5%lead
Year to date +18.4% +23.9%lead
1 year +28.3%lead +24.6%
2 years — +30.2%
52-week position 85% of range 98% of range
52-week range $123.24–$170.46 $435.27–$723.08
vs 50-day average above $149.25 above $664.82
vs 200-day average above $152.41 above $553.91
RSI (14) 65 60
Market cap—$266.1B
Analyst target — $756.52 (+5.3%)
Analysts—25
Consensus—Strong buy
Next earnings Oct 27, 2026 Jan 28, 2027

Where each one stands

NVS — Novartis AG

NVS trades at $163.26, above its 50-day average of $149.25, and above the 200-day at $152.41. It sits at 85% of its 52-week range ($123.24–$170.46); 14-day RSI is 65, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $168.62 (3.3% away) and the first support below is $160.57 (1.6% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

TMO — Thermo Fisher Scientific

TMO trades at $718.20, above its 50-day average of $664.82, and above the 200-day at $553.91. It sits at 98% of its 52-week range ($435.27–$723.08); 14-day RSI is 60, in neutral territory; an average session moves it about 3.1%. For levels, the first level overhead is $721.63 (0.5% away) and the first support below is $700.00 (2.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

Which one moves harder

TMO is the more volatile of the two — an average session moves it 3.1% against 2.3% for NVS, so an identical position size carries roughly 1.3× the daily risk.

What would change the picture

The comparison turns on those levels: NVS clearing $168.62 or losing $160.57; TMO clearing $721.63 or losing $700.00. Until one of them gives way, the relative reading above stands.

Questions people ask about NVS vs TMO

Which is performing better right now, NVS or TMO?
Over the past month NVS is +13.6% and TMO is +9.2%, so NVS is ahead on that window. Year to date the figures are +18.4% for NVS and +23.9% for TMO.
Which has done better over the last year, NVS or TMO?
Over the last year NVS is +28.3% and TMO is +24.6%, so NVS is ahead on that window.
Is NVS or TMO more volatile?
TMO is the more volatile of the two — an average session moves it 3.1% against 2.3% for NVS, so an identical position size carries roughly 1.3× the daily risk.
What are the key levels for NVS and TMO?
NVS: resistance $168.62, support $160.57; TMO: resistance $721.63, support $700.00. Levels come from recent swing zones and round numbers, recomputed daily.
When do NVS and TMO report next?
NVS: Oct 27, 2026. TMO: Jan 28, 2027. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the NVS/TMO ratio mean?
It is simply NVS's price divided by TMO's — 0.2273 today. When the ratio rises, NVS is outperforming; when it falls, TMO is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

NVS →
Novartis AG
Full technical brief: trend, levels, chart, news
TMO →
Thermo Fisher Scientific
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MerckLLY vs UNHLLY vs NVSAZN vs LLYLLY vs TMOAMGN vs LLY